Mazen Noureddin, MD
Enriched profileProfessor of Medicine · Houston Methodist Hospital
Mazen Noureddin is Professor of Medicine at Houston Methodist Hospital. ClinicalTrials.gov lists 2 registered studies with this person as an investigator.
Data verified 11 Oct 2026
Overview
Updated 14 Oct 2026
Mazen Noureddin, M.D., is Professor of Medicine at Houston Methodist Hospital. The public record shows 37 publications with 2,404 citations (h-index 12), centered on Fatty Liver, Fatty Liver, Alcoholic, NASH / NAFLD / MASH. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 34 companies, 1 NIH-funded awards (2026–2026).
- Top research focus: Fatty Liver
- 2 registered trials on ClinicalTrials.gov
- Open Payments reporting from 34 companies
Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 14 Oct 2026
Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:
- Assessment of Non-Invasive Testing in Major Liver-Related Outcomes
Sponsor: HRI-MAIL-NIT
- The Effect of Acetaminophen on Non-alcoholic Fatty Liver Disease Patients
Sponsor: University of Southern California
Industry payments
Updated 14 Oct 2026
34 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Madrigal PharmaceuticalsProgram year202555 payments$421,233openpaymentsdata.cms.gov ↗
- Novo Nordisk ASProgram year20256 payments$254,780openpaymentsdata.cms.gov ↗
- Boehringer Ingelheim International GmbHProgram year202516 payments$38,408openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
52.1%Bile Acid29.6%Ursodiol100%Part D≥14 patientsThyroid Hormone Receptor beta Agonist22.5%Rezdiffra100%Part D<11 patientsCardiovascular
40.8%Loop diuretic21.3%Furosemide100%Part D<11 patientsBeta blocker10.7%Carvedilol100%Part D<11 patients+ 1 more class in this area
Anti-infectives
7.1%Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor7.1%Epclusa100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 14 Oct 2026
1 NIH research award on record, funded 2026–2026 per NIH RePORTER. The latest:
- Non-Invasive Detection of Liver Fibrosis Utilizing the MASML Machine Learning Algorithm
Methodist Hospital Research Institute
FY2026$439,608R01DK143254
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Global epidemiology of alcohol-related liver disease, liver cancer, and alcohol use disorder, 2000–2021
Clinical and Molecular Hepatology
2025 - The Rising Global Burden of MASLD and Other Metabolic Diseases (2000–2021)
United European Gastroenterology Journal
2025
Background & recognition
Updated 14 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aasld.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aasld.org ↗
Editorial & leadership roles
journal and society appointments- Chair
AASLD MASLD Special Interest Group
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aasld.org ↗ - Associate Editor
Clinical Gastroenterology and Hepatology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aasld.org ↗ - Editorial board member
Gastroenterology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aasld.org ↗ - Editorial board member
Hepatology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aasld.org ↗ - Fellow
AASLD (FAASLD)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aasld.org ↗ - Chair
AASLD Annual Meeting Educational Committee
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →aasld.org ↗
Secondary affiliations
appointments beyond the home institution- Founder
Houston Research Institute
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aasld.org ↗ - Lynda K. and David M. Underwood Center for Digestive Disorders
J.C. Walter Jr. Transplant Center, and Sherrie & Alan Conover Center for Liver Disease & Transplantation, Houston Methodist Hospital
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aasld.org ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aasld.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
William Ondo, MD
Houston Methodist Hospital
Miguel Valderrabano, MD
Houston Methodist Hospital
Zeenat Safdar, MD
Houston Methodist Hospital
Charles Rice, MD
The Rockefeller University
Kris Kowdley, MD
Washington State University
Eamonn Quigley, MD
Houston Methodist Hospital and Academic Institute
Patrick Kamath, MD
Mayo Clinic